AURKA and neoplasm: To establish in vivo the therapeutic efficacy of dual TGF-β/AURKA-targeted therapy in combination with DTX, we used highly metastatic MDA-MB 231 LM cells infected with lenti-vectors expressing luciferase to monitor tumor growth in living animals as previously described [46].